| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62040b76107b9bddf644d26f4d747d56 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-531 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2011-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec456acd58022e2f39db844094accf6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d37eb46f27c2f6ddbd6bae51ff6c9d23 |
| publicationDate |
2013-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2544003-A1 |
| titleOfInvention |
Caveolin-1 in tumor-associated fibroblasts as biomarker for tumor progression |
| abstract |
The present invention refers to the use of caveolin-1 in tumor-associated fibroblasts as a biomarker of tumor progression, preferably using smooth muscle actin as biomarker for tumor-associated fibroblast. The present invention also relates to a method for the diagnosis and/or prognosis of tumor progression comprising the detection and/or quantification of caveolin-1 expression in the tumor-associated fibroblasts of an isolated sample. The present invention also refers Caveolin-1 inhibitors for use as a medicament and in the prevention of tumor progression. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108559777-A |
| priorityDate |
2011-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |